Exabis Library
Welcome to the e-CCO Library!
DOP27: Disease activity patterns in the first 5 years after diagnosis in children with Crohn’s disease: a population-based study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP27: Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn's Disease and chronic fatigue syndrome
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP27: Transanal minimally invasive surgery (TAMIS) – A noval approach for treatment of pouch failure
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP28: Aconitate decarboxylase 1 (ACOD1) represents a crucial regulator of monocyte recruitment, survival and proinflammatory status in intestinal inflammation
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP28: Yield of surveillance colonoscopy in patients with Primary Sclerosing Cholangitis
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP29: Capsule endoscopy-guided proactive treatment versus standard treatment of patients with quiescent Crohn’s Disease: The CURE-CD randomized controlled trial
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP29: Single cell analysis of Crohn’s disease fistula; comparison of different locations
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP30: Cross-ethnic microbiome analyses identify shared and specific signals for Northern Indian IBD patients
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP30: Identifying dietary factors and metabolites that may promote healthier Crohn Disease microbiome and mucosal transcriptomics signals as future targets using Diet-Omics
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP31: Gene correlation network analyses reveal transcript modules and pathogenic mechanisms associated with resistance and response to ustekinumab therapy in Ulcerative Colitis
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP31: Gut metabolomic and compositional signatures predict response to treatment with exclusive enteral nutrition in children with active Crohn’s disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP32: CD226+TIGITneg expression identifies pathogenic inflammatory CD4+ memory T cells in severe Crohn’s Disease patients, opening up opportunities for patient-tailored treatment strategies.
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP32: Crohn’s disease stricture matrisome analysis reveals the anti-fibrotic activity of milk-fat globule-epidermal growth factor 8 (MFGE8)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP33: Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP33: Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn’s disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP34: Deciphering immune-epithelial interactions in health and in Inflammatory Bowel Disease
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP34: Human MD2 deficiency - an inborn error of immunity predisposing to early onset Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP35: High-fat diet reduces gut microbiota-derived metabolite indole-acetic acid and aggravates colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP35: Spatial transcriptomics reveals cellular niches associated with histological inflammation in postoperative Crohn’s Disease
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP36: Vedolizumab-treated IBD patients show an increased gut microbial diversity associated with a specific serum metabolic signature
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM